{"transactions":[{"id":944416,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO & Treasurer"}}],"security":"Performance Stock Unit","published_at":"2026-01-07T16:18:01.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001488774-26-000002","document":"wk-form4_1767820678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000148877426000002/wk-form4_1767820678.xml","form_type":"4"}},{"id":944415,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-01-07T16:18:01.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":false,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001488774-26-000002","document":"wk-form4_1767820678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000148877426000002/wk-form4_1767820678.xml","form_type":"4"}},{"id":944414,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-01-07T16:18:01.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":false,"shares":86667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":86667},"source":{"system":"sec-edgar","filing":"0001488774-26-000002","document":"wk-form4_1767820678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000148877426000002/wk-form4_1767820678.xml","form_type":"4"}},{"id":944413,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-01-07T16:18:01.000Z","date":"2025-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":48513,"price":8.96,"value":434676.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to cover withholding taxes for the vested restricted stock units and performance stock units."}],"balance_after":143515,"source":{"system":"sec-edgar","filing":"0001488774-26-000002","document":"wk-form4_1767820678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000148877426000002/wk-form4_1767820678.xml","form_type":"4"}},{"id":944412,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-01-07T16:18:01.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":true,"shares":140667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued upon vesting of restricted stock units and performance stock units on December 31, 2025."}],"balance_after":192028,"source":{"system":"sec-edgar","filing":"0001488774-26-000002","document":"wk-form4_1767820678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000148877426000002/wk-form4_1767820678.xml","form_type":"4"}},{"id":1267258,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2025-02-14T17:55:01.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":7.861,"value":86471.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 10/15/2024"}],"balance_after":51361,"source":{"system":"sec-edgar","filing":"0001437749-25-004068","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774925004068/rdgdoc.xml","form_type":"4"}},{"id":1287300,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-03T17:20:36.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":34000,"derivative":{"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001437749-25-002625","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774925002625/rdgdoc.xml","form_type":"4"}},{"id":1287299,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO & Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-03T17:20:36.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":68000,"derivative":{"exercise_price":8.02,"expiration_date":"2035-01-29","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001437749-25-002625","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774925002625/rdgdoc.xml","form_type":"4"}},{"id":1287298,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-03T17:20:36.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":43333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":86667,"derivative":{"underlying":"Common Stock","underlying_shares":43333},"source":{"system":"sec-edgar","filing":"0001437749-25-002625","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774925002625/rdgdoc.xml","form_type":"4"}},{"id":1287297,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2025-02-03T17:20:36.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":43333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":62361,"source":{"system":"sec-edgar","filing":"0001437749-25-002625","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774925002625/rdgdoc.xml","form_type":"4"}},{"id":1452558,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2024-07-17T17:54:06.000Z","date":"2024-07-17","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":6.77,"value":13540.0,"ownership":{"direct":true},"balance_after":18469,"source":{"system":"sec-edgar","filing":"0001437749-24-022939","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774924022939/rdgdoc.xml","form_type":"4"}},{"id":1661591,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-02T20:11:48.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. \t Grant to the Reporting Person of restricted stock units (\"RSU\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 31, 2025, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's ongoing employment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 31, 2025, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's ongoing employment."}],"balance_after":130000,"derivative":{"underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001437749-24-003024","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774924003024/rdgdoc.xml","form_type":"4"}},{"id":1787118,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2023-09-06T17:11:19.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":4.9591,"value":4959.1,"ownership":{"direct":true},"balance_after":15309,"source":{"system":"sec-edgar","filing":"0001437749-23-025317","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774923025317/rdgdoc.xml","form_type":"4"}},{"id":1886832,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2023-05-18T16:56:04.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":689,"price":4.9495,"value":3410.2055,"ownership":{"direct":true},"balance_after":13742,"source":{"system":"sec-edgar","filing":"0001437749-23-015140","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774923015140/rdgdoc.xml","form_type":"4"}},{"id":1886831,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2023-05-18T16:56:04.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.9499,"value":9899.8,"ownership":{"direct":true},"balance_after":13053,"source":{"system":"sec-edgar","filing":"0001437749-23-015140","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774923015140/rdgdoc.xml","form_type":"4"}},{"id":1886830,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2023-05-18T16:56:04.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":51,"price":4.94,"value":251.94,"ownership":{"direct":true},"balance_after":11053,"source":{"system":"sec-edgar","filing":"0001437749-23-015140","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774923015140/rdgdoc.xml","form_type":"4"}},{"id":1956729,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2023-03-13T07:56:05.000Z","date":"2023-03-10","kind":"purchase","acquired":true,"shares":1725,"price":4.15,"value":7158.75,"ownership":{"direct":true},"balance_after":11002,"source":{"system":"sec-edgar","filing":"0001437749-23-006277","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774923006277/rdgdoc.xml","form_type":"4"}},{"id":2054769,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2023-01-13T17:28:17.000Z","date":"2023-01-13","kind":"purchase","acquired":true,"shares":25,"price":5.585,"value":139.625,"ownership":{"direct":true},"balance_after":9277,"source":{"system":"sec-edgar","filing":"0001437749-23-001060","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774923001060/rdgdoc.xml","form_type":"4"}},{"id":2054768,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2023-01-13T17:28:17.000Z","date":"2023-01-13","kind":"purchase","acquired":true,"shares":610,"price":5.82,"value":3550.2,"ownership":{"direct":true},"balance_after":9252,"source":{"system":"sec-edgar","filing":"0001437749-23-001060","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774923001060/rdgdoc.xml","form_type":"4"}},{"id":2056448,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-11T21:57:43.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":459726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on January 6, 2024 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":459726,"derivative":{"exercise_price":4.54,"expiration_date":"2033-01-08","underlying":"Common Stock","underlying_shares":459726},"source":{"system":"sec-edgar","filing":"0001437749-23-000919","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774923000919/rdgdoc.xml","form_type":"4"}},{"id":2147241,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2022-10-03T19:57:53.000Z","date":"2022-09-30","kind":"purchase","acquired":true,"shares":400,"price":5.983,"value":2393.2,"ownership":{"direct":true},"balance_after":8109,"source":{"system":"sec-edgar","filing":"0001437749-22-023512","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774922023512/rdgdoc.xml","form_type":"4"}},{"id":2147240,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2022-10-03T19:57:53.000Z","date":"2022-09-30","kind":"purchase","acquired":true,"shares":600,"price":5.98,"value":3588.0,"ownership":{"direct":true},"balance_after":7709,"source":{"system":"sec-edgar","filing":"0001437749-22-023512","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774922023512/rdgdoc.xml","form_type":"4"}},{"id":2265627,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2022-05-18T17:17:55.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":1200,"price":4.9992,"value":5999.04,"ownership":{"direct":true},"balance_after":6440,"source":{"system":"sec-edgar","filing":"0001437749-22-012932","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774922012932/rdgdoc.xml","form_type":"4"}},{"id":2413786,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T17:15:55.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":83486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on February 1, 2023 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":83486,"derivative":{"exercise_price":7.17,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":83486},"source":{"system":"sec-edgar","filing":"0001437749-22-002399","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774922002399/rdgdoc.xml","form_type":"4"}},{"id":2504731,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2021-11-18T16:57:39.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":510,"price":8.29,"value":4227.9,"ownership":{"direct":true},"balance_after":5240,"source":{"system":"sec-edgar","filing":"0001437749-21-027098","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774921027098/rdgdoc.xml","form_type":"4"}},{"id":2556551,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2021-09-29T16:10:59.000Z","date":"2021-09-29","kind":"purchase","acquired":true,"shares":215,"price":9.38,"value":2016.7,"ownership":{"direct":true},"balance_after":4730,"source":{"system":"sec-edgar","filing":"0001437749-21-022841","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774921022841/rdgdoc.xml","form_type":"4"}},{"id":2564006,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2021-09-20T17:03:14.000Z","date":"2021-09-20","kind":"purchase","acquired":true,"shares":935,"price":8.5865,"value":8028.3775,"ownership":{"direct":true},"balance_after":4515,"source":{"system":"sec-edgar","filing":"0001437749-21-022431","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774921022431/rdgdoc.xml","form_type":"4"}},{"id":2583458,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2021-09-01T16:04:27.000Z","date":"2021-09-01","kind":"purchase","acquired":true,"shares":230,"price":9.105,"value":2094.15,"ownership":{"direct":true},"balance_after":3580,"source":{"system":"sec-edgar","filing":"0001437749-21-021308","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774921021308/rdgdoc.xml","form_type":"4"}},{"id":2592214,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-24T16:49:02.000Z","date":"2021-08-20","kind":"grant","acquired":true,"shares":82423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on August 20, 2022 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":82423,"derivative":{"exercise_price":9.06,"expiration_date":"2031-08-19","underlying":"Common Stock","underlying_shares":82423},"source":{"system":"sec-edgar","filing":"0001437749-21-020862","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774921020862/rdgdoc.xml","form_type":"4"}},{"id":2655795,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2021-06-24T16:22:33.000Z","date":"2021-06-23","kind":"purchase","acquired":true,"shares":75,"price":14.11,"value":1058.25,"ownership":{"direct":true},"balance_after":3350,"source":{"system":"sec-edgar","filing":"0001437749-21-015562","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774921015562/rdgdoc.xml","form_type":"4"}},{"id":2693261,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2021-05-27T17:50:57.000Z","date":"2021-05-27","kind":"purchase","acquired":true,"shares":150,"price":9.85,"value":1477.5,"ownership":{"direct":true},"balance_after":3275,"source":{"system":"sec-edgar","filing":"0001437749-21-013577","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774921013577/rdgdoc.xml","form_type":"4"}},{"id":3046328,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2020-08-26T17:08:47.000Z","date":"2020-08-26","kind":"purchase","acquired":true,"shares":1000,"price":0.839,"value":839.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001437749-20-018766","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774920018766/rdgdoc.xml","form_type":"4"}},{"id":3054258,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2020-08-18T16:48:12.000Z","date":"2020-08-18","kind":"purchase","acquired":true,"shares":2000,"price":0.695,"value":1390.0,"ownership":{"direct":true},"balance_after":49000,"source":{"system":"sec-edgar","filing":"0001437749-20-018274","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774920018274/rdgdoc.xml","form_type":"4"}},{"id":3113346,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2020-06-11T16:10:15.000Z","date":"2020-06-11","kind":"purchase","acquired":true,"shares":1500,"price":0.1923,"value":288.45,"ownership":{"direct":true},"balance_after":47000,"source":{"system":"sec-edgar","filing":"0001437749-20-012894","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774920012894/rdgdoc.xml","form_type":"4"}},{"id":3135126,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2020-05-26T16:29:21.000Z","date":"2020-05-26","kind":"purchase","acquired":true,"shares":11500,"price":0.183,"value":2104.5,"ownership":{"direct":true},"balance_after":45500,"source":{"system":"sec-edgar","filing":"0001437749-20-011741","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774920011741/rdgdoc.xml","form_type":"4"}},{"id":3195406,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2020-03-25T17:37:35.000Z","date":"2020-03-25","kind":"purchase","acquired":true,"shares":1000,"price":0.2182,"value":218.2,"ownership":{"direct":true},"balance_after":34000,"source":{"system":"sec-edgar","filing":"0001437749-20-006118","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774920006118/rdgdoc.xml","form_type":"4"}},{"id":3213494,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2020-03-12T16:28:03.000Z","date":"2020-03-11","kind":"purchase","acquired":true,"shares":8000,"price":0.2513,"value":2010.4,"ownership":{"direct":true},"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001437749-20-004949","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774920004949/rdgdoc.xml","form_type":"4"}},{"id":3284458,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-07T21:38:00.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 50% of the shares underlying the option will vest upon the approval by the U.S. Food and Drug Administration of a new drug application for the Company's product candidate, KP415. The remaining 50% of the shares underlying the option will vest upon the approval of a label for KP415 which includes 30 minute onset and 13-hour duration (the \"30/13 Label\") as defined in the KP415 License Agreement dated September 3, 2019. Each vesting event is contingent upon such optionee's continued employment with the Issuer at the relevant vesting date as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":160000,"derivative":{"exercise_price":0.374,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001437749-20-002097","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774920002097/rdgdoc.xml","form_type":"4"}},{"id":3329768,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2019-12-30T16:26:36.000Z","date":"2019-12-27","kind":"purchase","acquired":true,"shares":2250,"price":0.4167,"value":937.575,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001437749-19-025002","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774919025002/rdgdoc.xml","form_type":"4"}},{"id":3329767,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2019-12-30T16:26:36.000Z","date":"2019-12-27","kind":"purchase","acquired":true,"shares":5000,"price":0.4175,"value":2087.5,"ownership":{"direct":true},"balance_after":22750,"source":{"system":"sec-edgar","filing":"0001437749-19-025002","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774919025002/rdgdoc.xml","form_type":"4"}},{"id":3329766,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2019-12-30T16:26:36.000Z","date":"2019-12-27","kind":"purchase","acquired":true,"shares":5000,"price":0.4169,"value":2084.5,"ownership":{"direct":true},"balance_after":17750,"source":{"system":"sec-edgar","filing":"0001437749-19-025002","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774919025002/rdgdoc.xml","form_type":"4"}},{"id":3357451,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-27T16:15:07.000Z","date":"2019-11-25","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 100% of the shares underlying the option will vest upon the acceptance of a new drug application for the Company's product candidate, KP415, by the U.S. Food and Drug Administration, provided that at the relevant vesting date such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":36000,"derivative":{"exercise_price":0.5161,"expiration_date":"2029-11-24","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001437749-19-023642","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774919023642/rdgdoc.xml","form_type":"4"}},{"id":3406289,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2019-09-25T20:58:02.000Z","date":"2019-09-25","kind":"purchase","acquired":true,"shares":3650,"price":0.7452,"value":2719.98,"ownership":{"direct":true},"balance_after":12750,"source":{"system":"sec-edgar","filing":"0001437749-19-019061","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774919019061/rdgdoc.xml","form_type":"4"}},{"id":3413868,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2019-09-16T16:59:19.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":4900,"price":0.8856,"value":4339.44,"ownership":{"direct":true},"balance_after":9100,"source":{"system":"sec-edgar","filing":"0001437749-19-018489","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774919018489/rdgdoc.xml","form_type":"4"}},{"id":3413867,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2019-09-16T16:59:19.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":100,"price":0.86,"value":86.0,"ownership":{"direct":true},"balance_after":4200,"source":{"system":"sec-edgar","filing":"0001437749-19-018489","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774919018489/rdgdoc.xml","form_type":"4"}},{"id":3417517,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2019-09-11T16:50:42.000Z","date":"2019-09-11","kind":"purchase","acquired":true,"shares":500,"price":0.9452,"value":472.6,"ownership":{"direct":true},"balance_after":4100,"source":{"system":"sec-edgar","filing":"0001437749-19-018218","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774919018218/rdgdoc.xml","form_type":"4"}},{"id":3420569,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2019-09-06T17:06:01.000Z","date":"2019-09-06","kind":"purchase","acquired":true,"shares":850,"price":0.7674,"value":652.29,"ownership":{"direct":true},"balance_after":3600,"source":{"system":"sec-edgar","filing":"0001437749-19-018003","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774919018003/rdgdoc.xml","form_type":"4"}},{"id":3668051,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-08T17:36:33.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on February 6, 2020 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":160000,"derivative":{"exercise_price":2.66,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001437749-19-002169","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774919002169/rdgdoc.xml","form_type":"4"}},{"id":3792412,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2018-10-11T18:52:29.000Z","date":"2018-10-11","kind":"purchase","acquired":true,"shares":650,"price":2.5414,"value":1651.91,"ownership":{"direct":true},"balance_after":2750,"source":{"system":"sec-edgar","filing":"0001437749-18-018208","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774918018208/rdgdoc.xml","form_type":"4"}},{"id":3910707,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2018-06-01T16:14:22.000Z","date":"2018-05-31","kind":"purchase","acquired":true,"shares":525,"price":6.1,"value":3202.5,"ownership":{"direct":true},"balance_after":2100,"source":{"system":"sec-edgar","filing":"0001437749-18-011084","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774918011084/rdgdoc.xml","form_type":"4"}},{"id":4086537,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-29T18:56:18.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on January 25, 2019 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":5.5,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-18-001303","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774918001303/rdgdoc.xml","form_type":"4"}},{"id":4202451,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2017-09-25T16:33:20.000Z","date":"2017-09-25","kind":"purchase","acquired":true,"shares":300,"price":3.775,"value":1132.5,"ownership":{"direct":true},"balance_after":1575,"source":{"system":"sec-edgar","filing":"0001437749-17-016324","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774917016324/rdgdoc.xml","form_type":"4"}},{"id":4275277,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2017-06-21T08:57:53.000Z","date":"2017-06-19","kind":"purchase","acquired":true,"shares":275,"price":3.3,"value":907.5,"ownership":{"direct":true},"balance_after":1275,"source":{"system":"sec-edgar","filing":"0001437749-17-011574","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774917011574/rdgdoc.xml","form_type":"4"}},{"id":4371516,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2017-03-27T16:28:09.000Z","date":"2017-03-24","kind":"purchase","acquired":true,"shares":100,"price":4.2436,"value":424.36,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001437749-17-005323","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774917005323/rdgdoc.xml","form_type":"4"}},{"id":4371515,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Common Stock","published_at":"2017-03-27T16:28:09.000Z","date":"2017-03-24","kind":"purchase","acquired":true,"shares":900,"price":4.2437,"value":3819.33,"ownership":{"direct":true},"balance_after":900,"source":{"system":"sec-edgar","filing":"0001437749-17-005323","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774917005323/rdgdoc.xml","form_type":"4"}},{"id":4475326,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":69837,"kind":"person","name":"Clifton R. LaDuane","position":1,"cik":"0001488774","reported_name":"Clifton R. LaDuane","relationship":{"officer":true,"officer_title":"CFO, Secretary & Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-31T16:58:57.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on January 27, 2018 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":3.55,"expiration_date":"2027-01-26","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-17-001389","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488774/000143774917001389/rdgdoc.xml","form_type":"4"}}]}